RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Omonike Olaleye to Clioquinol

Back to Details
This is a "connection" page, showing publications Omonike Olaleye has written about Clioquinol.
Omonike Olaleye
Connection Strength
1.246
Clioquinol
  1. Kehinde IA, Egbeyemi A, Kaur M, Onyenaka C, Adebusuyi T, Olaleye OA. Inhibitory mechanism of clioquinol and its derivatives at the exopeptidase site of human angiotensin-converting enzyme-2 and receptor binding domain of SARS-CoV-2 viral spike. J Biomol Struct Dyn. 2023 04; 41(7):2992-3001.
    View in: PubMed
    Score: 0.836
  2. Olaleye O, Raghunand TR, Bhat S, Chong C, Gu P, Zhou J, Zhang Y, Bishai WR, Liu JO. Characterization of clioquinol and analogues as novel inhibitors of methionine aminopeptidases from Mycobacterium tuberculosis. Tuberculosis (Edinb). 2011 Dec; 91 Suppl 1:S61-5.
    View in: PubMed
    Score: 0.410
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support